Insulin infusion device maker CeQur raises $100 mln
September 01, 2015 at 06:53 AM EDT
LONDON, Sept 1 (Reuters) - Privately held company CeQur, which is developing the world's first three-day insulin infusion device for people with type 2 diabetes, has raised $100 million in a funding round that shows strong investor appetite for hot medical technology.
